Drugs & Targets FDA approves Darzalex for newly diagnosed multiple myeloma patients who are transplant ineligible May 11, 2018Vol.44 No.19
Drugs & Targets Lynparza approved by EMA for epithelial ovarian, fallopian tube or primary peritoneal cancer May 11, 2018Vol.44 No.19
Drugs & TargetsFree Novartis’ Kymriah gets second FDA approval—for large B-cell lymphoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree FDA approves Tafinlar and Mekinist for BRAF V600-mutant melanoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree FDA grants priority review to cemiplimab in advanced cutaneous squamous cell carcinoma May 04, 2018Vol.44 No.18
Drugs & TargetsFree Genocea files IND for neoantigen cancer vaccine candidate GEN-009 May 04, 2018Vol.44 No.18
Drugs & TargetsFree Mylotarg approved in EU for previously untreated, de novo, CD33-positive AML in combination with Chemotherapy April 27, 2018Vol.44 No.17
Drugs & TargetsFree Nektar, Takeda to evaluate combining CD122-biased agonist and dual SYK and FLT-3 inhibitor April 27, 2018Vol.44 No.17
